Shire studies Takeda takeover bid
Shire is considering a new offer from Takeda Pharmaceutical Co. after the Japanese drugmaker revised its roughly $60 billion bid for the biotechnology company once again. Shire’s board “is considering its position” on a new bid, the company said Tuesday after Bloomberg News reported that the companies were nearing a preliminary agreement. The Massachusetts drugmaker did not disclose the value of Takeda’s latest offer. The new proposal marks at least the fifth attempt... Читать дальше...